General Methods
THF was distilled from potassium under argon. Diethylether and toluene were distilled from sodium/benzophenone ketyl under argon. CH 2 Cl 2 was distilled from P 4 O 10 and passed over neutral aluminum oxide. All solvents were used directly after purification, or were stored over molecular sieves under argon until use. Triethylamine and N,N-diisopropylethylamine were distilled from calcium hydride directly prior to use. All other commercially available reagents were used as received.
Reactions were carried out in pre-dried glassware under an argon atmosphere and were monitored by TLC on Merck silica gel 60-F254 glass plates. Spots were detected using UV light (254 nm) or stained using CAM (22 mL H 2 SO 4 conc., 20 g phosphomolybdic acid, 0.5 g cerium(IV) sulfate, 380 mL water) or silica/iodine. Flash chromatography was performed on Merck silica gel 60 (40-63 μm, 230-400 mesh). Analytical and preparative HPLC was performed on Macherey-Nagel Nucleosil 50 (4 μm) columns. Yields are reported as obtained after chromatographic purification, unless noted otherwise.
NMR spectra were recorded on Bruker Avance AV 400 or DRX 400 spectrometers in CDCl 3 , unless noted otherwise. Chemical shifts are reported in ppm relative to the residual peak of the deuterated solvent (7.26 and 77.00 for CDCl 3 for 1 H and 13 C NMR, respectively). HRMS data were obtained on Bruker Maxis and Finnigan MAT 8230 spectrometers. IR data were recorded on a Bruker Vertex 70 FTIR spectrometer equipped with an ATR unit. Optical rotations were measured on a P341 PerkinElmer polarimeter at 20°C.
Experimental Part (3S,4S)-5-((tert-Butyldimethylsilyl)oxy)-4-methylpent-1-en-3-ol (14)
Diol S1 2 (17.7 g, 152 mmol) was dissolved in CH 2 Cl 2 (400 mL) and cooled to 0°C. Triethylamine (27.4 mL, 198 mmol) and TBSCl (25.2 g, 167 mmol) were added and the solution was allowed to warm to room temperature overnight. The mixture was quenched with NH 4 Cl aq. sat. (250 mL), the phases were separated and the aqueous layer was extracted with CH 2 Cl 2 (3 x 150 mL). The combined organic phases were washed with brine, dried over Na 2 SO 4 , and the solvents were removed. Flash chromatography (hexanes/EtOAc 9:1) delivered 14 (33.2 g, 95%) as a colorless oil. [α] D 20 = -12.0° (10 mg/mL, CHCl 3 ). These data are consistent with previously reported values. To a solution of 14 3 (13.0 g, 61.9 mmol) in THF (50 mL) was added N,N-diisopropylcarbodiimide (9.6 mL, 61.9 mmol) at 0 °C. After 10 min, a heavy precipitate had formed. A solution of 19 (9.5 g, 41.3 mmol) in THF (20 mL) was added, followed by 4-dimethylaminopyridine (0.5 g, 4.1 mmol). The mixture was allowed to warm to room temperature overnight. A solution of 8 (1.00 g, 2.26 mmol) in toluene (15 mL) was cooled to -78 °C under argon. KHMDS (1.56 g, 7.81 mmol) in toluene (15 mL) was slowly added at -78°C, whereupon the mixture turned yellow. After 1 h of stirring at this temperature, TMSCl (0.93 mL, 7.34 mmol) was added via a syringe and the solution was allowed to warm to room temperature overnight. The reaction was quenched by addition of NH 4 Cl aq. sat. (30 mL) and the pH was adjusted to 4 using 1 M HCl aq. The phases were separated and the aqueous layer was extracted with EtOAc (5 x 75 mL). The combined organic phases were washed with brine, dried over Na 2 SO 4 , and the solvents were removed. The crude product 15 was used directly in the next step. A small amount of material was subjected to column chromatography and HPLC purification to obtain pure material for analytical data. 
(2R,6R,E)-7-((tert-Butyldimethylsilyl)oxy)-N-methoxy-2-((4-methoxybenzyl)oxy)-N,2,6-trimethylhept-4-enamide (7)
Crude 17 (100% yield assumed, 2.37 mmol) was dissolved in CH 2 Cl 2 (10 mL) under argon and cooled to 0°C. Then, N,N-diisopropylcarbodiimide (0.40 mL, 2.60 mmol) was added and the mixture was stirred at 0°C for 20 minutes, whereupon a precipitate formed. Triethylamine (0.40 mL, 2.84 mmol), N,O-dimethylhydroxylamine hydrochloride (277 mg, 2.84 mmol) and N,N-dimethylaminopyridine (29 mg, 0.24 mmol) were added. The solution was allowed to warm to room temperature overnight.
The CH 2 Cl 2 was removed and the residue was redissolved in THF. The insoluble urea was filtered and extracted with THF. The solvents were removed from the combined organic phases. The crude product was purified by flash chromatography (hexanes/EtOAc 5:1, dry load) and amide 7 (1.33 g, 56% over two steps) was isolated as a slightly yellow oil. 
(2R,6R,E)-7-((tert-Butyldimethylsilyl)oxy)-2-((4-methoxybenzyl)oxy)-2,6-dimethylhept-4-enal (26)
To a solution of the amide 7 (7.80 g, 16.8 mmol) in diethylether (170 mL) was added DIBAL-H (1.0 M in heptanes, 26.8 mL, 26.8 mmol) dropwise at -78°C. After 1 h of stirring at -78°C, the mixture was quenched with NH 4 Cl aq. sat. (100 mL). Saturated Rochelle salt solution (100 mL) was added and the biphasic mixture was vigorously stirred for 90 minutes. The phases were separated and the aqueous layer was extracted with CH 2 Cl 2 (3 x 100 mL). The combined organic phases were washed with brine and dried over Na 2 SO 4 . The solvents were removed and the crude product was purified by flash chromatography (hexanes/EtOAc 5:1) to give 6.32 g of 26 (93%) as a colorless oil. [α] D 20 = +23.4° (10 mg/mL, CHCl 3 ).
(5R,6R,10R,E)-11-((tert-Butyldimethylsilyl)oxy)-5-hydroxy-6-((4-methoxybenzyl)oxy)-6,10-dimethyl-1-(trimethylsilyl)undec-8-en-1-yn-3-one (32)
To a solution of 34 (3.62 mL, 0.1 M in THF, 0.362 mmol) was added 35 (2.380 ml, 14.49 mmol) at -45°C and the mixture was stirred for 15 min. Then, a solution of 26 (0.982 g, 2.415 mmol) in 1.3 mL THF was added and the mixture was stirred at -30°C overnight. The mixture was quenched with NH 4 Cl aq. sat. (10 mL), the phases were separated, and the aqueous layer was extracted with EtOAc three times. The combined organic phases were dried over Na 2 SO 4 , filtered, and the solvents were removed. The crude product was purified by column chromatography (hexanes/EtOAc 9:1) at -25°C to give the undesired epimer epi-32 (384 mg, eluted first) and 32 (620 mg, eluted second), both as colorless oils, in a combined yield of 76% and a dr of 1.6:1.
The setup for low-temperature column chromatography is shown in the figure below. A cold bath was cooled to -30 °C using a cooling finger. The eluent was run through the cooling bath in Teflon tubing, before being applied onto the top of a column with heating/cooling mantle through a septum. The column itself was additionally cooled by circulating the cooling mixture through its mantle using a pump. All tubing and the column itself was isolated using cotton wool and aluminium foil. Once the temperature had stabilized (usually around -25°C), the crude mixture was dissolved in the eluent and applied to the top of the column through the septum using a syringe. Fractions were then collected until complete elution of the product.
Analytical data for the undesired isomer (epi-32, eluting 
(5R,6R,10R,E)-11-((tert-Butyldimethylsilyl)oxy)-6-((4-methoxybenzyl)oxy)-5-(methoxymethoxy)-6,10-dimethyl-1-(trimethylsilyl)undec-8-en-1-yn-3-one (S2)
A suspension of 32 (562 mg, 1.028 mmol) in a minimum amount of CH 2 Cl 2 was cooled to 0°C and N,Ndiisopropylethylamine (2.15 mL, 12.3 mmol) and methoxymethyl bromide (839 μL, 10.28 mmol) were added. The mixture was slowly warmed to room temperature. After 1 h, before complete consumption of the starting material, the reaction was quenched by addition of NH 4 Cl aq. sat. (10 mL). Prolonged reaction times led to lower yields due to decomposition. The phases were separated, and the aqueous layer was extracted with diethylether three times. The combined organic phases were dried over Na 2 SO 4 , filtered, and the solvents were removed. The crude product was purified using column chromatography (hexanes/EtOAc 9:1) at -25°C to give S2 (249 mg, 41%) as colorless oil, along with unreacted 32 (167.8 mg, 30%). [α] D 20 = +45.4° (10 mg/mL, CHCl 3 ).
(3R,5R,6R,10R,E)-11-((tert-Butyldimethylsilyl)oxy)-6-((4-methoxybenzyl)oxy)-5-(methoxymethoxy)-6,10-dimethylundec-8-en-1-yn-3-ol (S3).
To 33 (166 mg, 0.281 mmol) in absolute methanol (1.4 mL) was added powdered potassium carbonate (19.4 mg, 0.140 mmol) at 0°C. The mixture was stirred at 0°C, then allowed to warm to room temperature overnight. The reaction was diluted with diethylether (10 mL), and quenched with NH 4 Cl aq. sat. (10 mL). The phases were separated and the aqueous layer was extracted with diethylether three times. The combined organic phases were dried over Na 2 SO 4 , and the solvents were removed under reduced pressure. The crude product was purified by column chromatography (hexanes/EtOAc 5:1) to yield S3 (130 mg, 89%) as a colorless oil. To S3 (105 mg, 0.202 mmol) in N,N-dimethylformamide (2 mL) was added sodium hydride (16 mg, 0.405 mmol). Then PMBCl (55 μl, 0.405 mmol) was added and the mixture was stirred at room temperature until completion (roughly 3.5 h). The reaction was quenched by addition diethylether (10 mL) and NH 4 Cl aq. sat. (10 mL). The phases were separated, and the aqueous layer was extracted with diethylether three times. The combined organic phases were dried over Na 2 SO 4 , filtered, and the solvents were removed. The crude product was purified using column chromatography (hexanes/EtOAc 19:1) to give S4 (110 mg, 85%) as a colorless oil.
Selected Spectra

